One of the services provided by the Australian National Diabetes Services Scheme (NDSS) is access to insulin pump consumables (reservoirs and infusion sets). Occasionally there are changes to the products available, and another such change quietly slipped in last week. A range of Medtronic infusion sets have just been taken off the market. Who is affected? Basically, …
April NDSS changes – Medtronic drops some infusion sets Read More »
Standard Deviation, Time in Range, HbA1c, etc. Do they correlate in any way? Sure they give us information about how our blood glucose levels have been tracking over the previous few months. But most of us only look at the latest figures. I showed my own latest data in yesterday’s “What’s normal?” post. In preparing for my latest endocrinologist …
So another quarter has rolled around, and another blood test has been done. Here’s an analysis of my last 90 days of CGM data. This goes back to mid-December 2019 (so includes Christmas/NY). Compared with lab HbA1c Each day is different, but the above data is an average over the last 90 days. For the …
Dexcom’s G6 CGM looks like it’s finally coming to Australia. This article is an attempt to distill the answers to most of the common questions in one place. That is, the answers we know at this point. February 2020 The G6 system was introduced in the US in 2018. This week Australia’s TGA approved the …
Continuous Glucose Monitoring gives us lots of data, and various attempts have been made to distill it down into simple metrics. This is a difficult job as there can be a huge depth of data available in there, which can be lost if we only look at high level numbers. But people are used to …
What are “diabetes complications”? This is a term I have real problems with: it’s misleading, and has unfortunate impacts on everyone. I tend to think of there not actually being any such thing as a “diabetes complication”. There’s usually nothing “diabetic” about health complications. What are people referring to? Basically, at a crude level it’s about …